Can You Take Ibuprofen with Duloxetine?

Severity assessment

Moderate. The primary risk is an increased likelihood of bleeding, particularly gastrointestinal bleeding, due to the combined effects of both medications on platelet function and gastrointestinal mucosa [1, 2, 3].

Mechanism (plain English)

Duloxetine, a medication often used for depression, anxiety, and certain types of pain, works by increasing the levels of chemical messengers called serotonin and norepinephrine in the brain. Serotonin also plays a role in blood clotting, and duloxetine can reduce the amount of serotonin available in platelets, which are tiny blood cells essential for stopping bleeding. This can make it harder for blood to clot normally [3, 4].

Ibuprofen is a common pain reliever and anti-inflammatory drug that belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). Ibuprofen works by blocking substances in the body that cause pain and inflammation. However, it also interferes with the function of platelets, making them less sticky and less able to form clots. Additionally, NSAIDs like ibuprofen can irritate the lining of the stomach and intestines, increasing the risk of ulcers and bleeding in the digestive tract [1, 3].

When duloxetine and ibuprofen are taken together, their individual effects on blood clotting and the gastrointestinal lining are combined, leading to a significantly higher risk of bleeding than when either medication is taken alone [1, 3].

Evidence level

Regulator-flagged. The interaction is highlighted in prescribing information from regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the UK's National Institute for Health and Care Excellence (NICE) via the British National Formulary (BNF) [2, 3].

Top regulator advisories (cite verbatim or close paraphrase)

• TGA (Australia): No pair-specific public advisory found for duloxetine and ibuprofen. However, the Australian Public Assessment Report (AusPAR) for duloxetine (Cymbalta) notes that in some clinical studies, patients were allowed to continue NSAID use, with NSAID use being a stratifying variable [5]. For general duloxetine product information, refer to ARTG entries such as APO-DULOXETINE (ARTG 427037) [6].
• MHRA / NICE (UK): The British National Formulary (BNF) states: "Both Duloxetine and Ibuprofen can increase the risk of bleeding. Severity: Severe." [2].
• FDA (US): The prescribing information for Cymbalta (duloxetine) warns: "Increased Risk of Bleeding: May increase the risk of bleeding events. Concomitant use of antiplatelet drugs and anticoagulants may increase this risk" (Sections 5.5, 7.4, 8.1) [3].
• EMA (Europe): No specific EMA advisory for duloxetine and ibuprofen interaction was readily found in the search results.

Clinical risk factors that elevate the danger

Several factors can increase the risk of bleeding when duloxetine and ibuprofen are used concurrently:

• Older age: Elderly patients are generally more susceptible to bleeding complications [1].
• History of gastrointestinal bleeding or ulcers: Individuals with a past history of stomach or intestinal bleeding are at a much higher risk [1].
• Concomitant use of other medications that affect bleeding: This includes other NSAIDs, aspirin, anticoagulants (e.g., warfarin, apixaban), antiplatelet agents (e.g., clopidogrel), and other serotonergic drugs [1, 3].
• Kidney or liver disease: Impaired kidney or liver function can affect how these drugs are processed and eliminated from the body, increasing drug levels and the risk of side effects [1].
• Alcohol consumption: Alcohol can further irritate the stomach lining and increase the risk of gastrointestinal bleeding [1].
• Prolonged use of NSAIDs: Long-term use of ibuprofen increases the risk of gastrointestinal adverse events [1].

What a patient should be told

• Taking duloxetine and ibuprofen together can increase your risk of bleeding, especially in your stomach or intestines. This risk is serious, so it's important to be aware of the warning signs.
• Do not stop taking either medication suddenly without talking to your doctor or pharmacist first. They can help you manage your medications safely.
• Watch out for warning signs of bleeding, such as unusual bruising, black or tarry stools, blood in your vomit (which might look like coffee grounds), or persistent stomach pain. If you experience any of these, seek medical attention immediately.
• Discuss safer alternatives with your doctor or pharmacist if you are concerned about this interaction. They may suggest different pain relief options or adjust your medication regimen.
• Seek urgent medical care if you experience severe stomach pain, significant bleeding, dizziness, lightheadedness, or weakness, as these could be signs of serious internal bleeding.

Top 3 sources (with full citation)

1. Drugs.com. Duloxetine and Ibuprofen: Can You Take Them Together? Drugs.com. Available at: https://www.drugs.com/drug-interactions/duloxetine-with-ibuprofen-949-0-1310-0.html
2. NICE. Duloxetine | Interactions | BNF. National Institute for Health and Care Excellence. Available at: https://bnf.nice.org.uk/interactions/duloxetine/
3. U.S. Food and Drug Administration. Cymbalta (duloxetine delayed-release capsules) Prescribing Information. Revised: 04/2020. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021427s052lbl.pdf

Notes for the reviewing pharmacist

The interaction between duloxetine and ibuprofen is well-established and primarily centers on an increased risk of bleeding, particularly gastrointestinal. While the FDA label for duloxetine provides a general warning about concomitant use with antiplatelet drugs, the BNF explicitly flags the duloxetine-ibuprofen interaction as "Severe." This discrepancy in explicit severity labeling across regulators might be due to varying reporting thresholds or emphasis. Pharmacists should counsel patients on the additive antiplatelet effects and gastric irritation potential. It is crucial to assess individual patient risk factors, including age, history of GI issues, and concurrent use of other medications affecting hemostasis. Education on bleeding symptoms and when to seek urgent care is paramount. In Australia, while no specific TGA advisory for this pair was found, the general product information for duloxetine should be consulted, and the principles of managing concomitant serotonergic agents and NSAIDs should be applied.